Vyxeos Interactions
There are 523 drugs known to interact with Vyxeos (cytarabine liposomal/daunorubicin liposomal), along with 6 disease interactions. Of the total drug interactions, 113 are major, 403 are moderate, and 7 are minor.
- View all 523 medications that may interact with Vyxeos
- View Vyxeos disease interactions (6)
Most frequently checked interactions
View interaction reports for Vyxeos (cytarabine liposomal / daunorubicin liposomal) and the medicines listed below.
- Abbokinase (urokinase)
- acetaminophen / chlorpheniramine / dextromethorphan / guaifenesin / phenylephrine
- Actiq (fentanyl)
- Activase (alteplase)
- Adriamycin (doxorubicin)
- Arixtra (fondaparinux)
- atomoxetine
- Azedra (iobenguane I 131)
- Azilect (rasagiline)
- azithromycin
- bleomycin
- Blocadren (timolol)
- Bosulif (bosutinib)
- calcitonin
- Cepastat Sore Throat & Cough (benzocaine / dextromethorphan / menthol topical)
- Ceprotin (protein c)
- Coreg CR (carvedilol)
- cyclophosphamide
- cycloserine
- DepoCyt (cytarabine liposomal)
- Desoxyn Gradumet (methamphetamine)
- dexamethasone
- Dibenzyline (phenoxybenzamine)
- Dilantin (phenytoin)
- Edurant (rilpivirine)
- Eliquis (apixaban)
- Etopophos (etoposide)
- Evrysdi (risdiplam)
- fluoride
- Givlaari (givosiran)
Vyxeos disease interactions
There are 6 disease interactions with Vyxeos (cytarabine liposomal / daunorubicin liposomal) which include:
- infections
- meningeal infection
- myelosuppression
- congestive heart failure
- infections
- myelosuppression
Report options
More about Vyxeos (cytarabine liposomal / daunorubicin liposomal)
- Vyxeos consumer information
- Compare alternatives
- Pricing & coupons
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: antineoplastic combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Venclexta
Venclexta may be used to treat chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Daunorubicin
Daunorubicin systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, acute ...
Revumenib
Revumenib systemic is used for acute lymphoblastic leukemia, acute myeloid leukemia, leukemia
Ivosidenib
Ivosidenib systemic is used for acute myeloid leukemia, biliary tract tumor, myelodysplastic syndrome
Azacitidine
Azacitidine systemic is used for acute myeloid leukemia, myelodysplastic syndrome
Cytarabine
Cytarabine systemic is used for acute myeloid leukemia, acute nonlymphocytic leukemia, chronic ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.